Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Revenue | 45.45 | 52.23 | 51.39 | 51.78 |
Total Revenue | 45.45 | 52.23 | 51.39 | 51.78 |
Costof Revenue Total | 3.85 | 6.77 | 11.44 | 7.21 |
Gross Profit | 41.60 | 45.46 | 39.95 | 44.57 |
Selling/ General/ Admin Expenses Total | 20.51 | 23.96 | 24.14 | 26.91 |
Depreciation/ Amortization | 9.29 | 9.27 | 7.45 | 5.59 |
Other Operating Expenses Total | 0.00 | 0.00 | 0.00 | 0.00 |
Total Operating Expense | 33.65 | 39.99 | 43.02 | 39.70 |
Operating Income | 11.80 | 12.24 | 8.37 | 12.07 |
Interest Inc( Exp) Net- Non- Op Total | -77.78 | -76.51 | -39.93 | -30.51 |
Other Net | 0.04 | 0.04 | 0.10 | -0.40 |
Net Income Before Taxes | 4.06 | 4.62 | 4.47 | 8.62 |
Provisionfor Income Taxes | 1.53 | 1.97 | 2.27 | 2.94 |
Net Income After Taxes | 2.53 | 2.65 | 2.20 | 5.68 |
Net Income Before Extra Items | 2.53 | 2.65 | 2.20 | 5.68 |
Net Income | 2.53 | 2.65 | 2.20 | 5.68 |
Income Availableto Com Excl Extra Ord | 2.53 | 2.65 | 2.20 | 5.68 |
Income Availableto Com Incl Extra Ord | 2.53 | 2.65 | 2.20 | 5.68 |
Diluted Net Income | 2.53 | 2.65 | 2.20 | 5.68 |
Diluted Weighted Average Shares | 1.67 | 1.48 | 1.42 | 1.34 |
Diluted EPS Excluding Extra Ord Items | 1.51 | 1.79 | 1.55 | 4.23 |
Diluted Normalized EPS | 1.51 | 1.79 | 1.55 | 4.23 |
Total Adjustmentsto Net Income | - | 0.00 | - | - |
Vivo Bio Tech Dividend Vivo Bio Tech Bonus Vivo Bio Tech News Vivo Bio Tech AGM Vivo Bio Tech Rights Vivo Bio Tech Splits Vivo Bio Tech Board Meetings Vivo Bio Tech Key Metrics Vivo Bio Tech Shareholdings Vivo Bio Tech Balance Sheet Vivo Bio Tech Cashflow Vivo Bio Tech Q1 Results Vivo Bio Tech Q2 Results Vivo Bio Tech Q3 Results Vivo Bio Tech Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks